SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-000444
Filing Date
2023-01-24
Accepted
2023-01-24 16:30:54
Documents
16
Period of Report
2023-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_012423.htm   iXBRL 8-K 14420
2 PRESS RELEASE exh_991.htm EX-99.1 17195
7 GRAPHIC figure1.jpg GRAPHIC 22917
8 GRAPHIC figure2.jpg GRAPHIC 29755
  Complete submission text file 0001171843-23-000444.txt   309586

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
10 EXTRACTED XBRL INSTANCE DOCUMENT f8k_012423_htm.xml XML 3048
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 23548504
SIC: 2834 Pharmaceutical Preparations